Skin Microbiome Variation: Indicator or Risk Factor for Squamous Cell Carcinoma?
The skin microbiome may serve as biomarker for skin cancer progression.
The skin microbiome may serve as biomarker for skin cancer progression.
Researchers sought to investigate the connection between immune checkpoint inhibitors (ICIs) and immune- and autoimmune-related adverse events in older patients diagnosed with melanoma.
The intervention would yield a net monetary benefit of £10.6 million and a net health benefit of 530 QALYs, researchers found.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
More than half of melanoma cases diagnosed among White patients in 2014 may represent cases of overdiagnosis, a study suggests.
Ipilimumab plus nivolumab demonstrated efficacy in a phase 2 trial of patients with advanced melanoma who failed prior anti-PD-1 therapy.
A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.
The incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of Virchow’s node.
Patients in the very high risk group had a significantly higher risk of recurrence, metastasis, and death.